• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

New Investor Presentation from Zynerba Pharmaceuticals

January 5, 2018

|

Steven Lachard

 

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) just released its January 2018 investor presentation, and we think it's worth taking a look! Scroll through the slides below for an in-depth look at what's going on at Zynerba. 

 

 

To stay up to date with important developments in the cannabis industry, be sure to subscribe to one or more of our free email newsletters. Also, connect with The Daily Marijuana Observer on Facebook, Twitter, StockTwits and Instagram!

 

D/M/O

Read more articles tagged:

investor presentation

Zynerba Pharmaceuticals

ZYNE

Please reload

LATEST NEWS

Facts You Need to Know About Cannabis

October 15, 2020

5 Products Every Vegan Needs When Traveling

October 6, 2020

Quintessential Californian Edible Recipes to Make...

October 2, 2020

How Does Smoking Cannabis Contribute to Your Socia...

April 8, 2020

Can You Strengthen Your Immune System With Cannabi...

April 8, 2020

50 Blue Chip Stocks Worth Less than Half as Much a...

September 19, 2018

5 of Today's Biggest Marijuana Stock Losers -...

September 10, 2018

5 of Today's Biggest Marijuana Stock Gainers -...

September 5, 2018

5 of Today's Biggest Marijuana Stock Losers -...

September 5, 2018

5 of Today's Biggest Marijuana Stock Gainers -...

September 4, 2018

Please reload

Roth Capital Upgraded Zynerba to a Buy Rating

August 16, 2017

Trading Marijuana Stocks With Ally Invest

August 7, 2017

7 Things To Know About Zynerba's Pipeline & Q2 Earnings Release

August 2, 2017

Zynerba Reaches Target Enrollment in Phase 2 Fragile X Study

June 8, 2017

Zynerba to Present at Jefferies Healthcare Conference

June 1, 2017

Insider Buying by CEO & CFO at Zynerba Pharmaceuticals

May 19, 2017

1/1
Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.